Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity (2017)
- Authors:
- Autor USP: SHINJO, SUELI MIEKO OBA - FM
- Unidade: FM
- Subjects: MIOSITE; FÁRMACOS IMUNOSSUPRESSORES; EVENTO ADVERSO A MEDICAMENTO
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinical and experimental rheumatology
- ISSN: 0392-856X
- Volume/Número/Paginação/Ano: v. 35, n. 6, p. 1011-1013, 2017
-
ABNT
SOUZA, R. C. de et al. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity. Clinical and experimental rheumatology, v. 35, n. 6, p. 1011-1013, 2017Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/25488. Acesso em: 03 jan. 2026. -
APA
Souza, R. C. de, Souza, F. H. C. de, Miossi, R., & Shinjo, S. M. O. (2017). Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity. Clinical and experimental rheumatology, 35( 6), 1011-1013. Recuperado de http://observatorio.fm.usp.br/handle/OPI/25488 -
NLM
Souza RC de, Souza FHC de, Miossi R, Shinjo SMO. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity [Internet]. Clinical and experimental rheumatology. 2017 ; 35( 6): 1011-1013.[citado 2026 jan. 03 ] Available from: http://observatorio.fm.usp.br/handle/OPI/25488 -
Vancouver
Souza RC de, Souza FHC de, Miossi R, Shinjo SMO. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity [Internet]. Clinical and experimental rheumatology. 2017 ; 35( 6): 1011-1013.[citado 2026 jan. 03 ] Available from: http://observatorio.fm.usp.br/handle/OPI/25488 - Alta prevalência de tabagismo em pacientes com artrite reumatóide de início precoce
- Lysyloxidase related genes identification by siRNA knockdown
- Endothelial function features and properties of large vessel behavior in systemic autoimmune diseases: a cross-talk among cardiovascular disease risk factors
- Hyaluronic acid in dermatomyositis and polymyositis: relationship with disease and cutaneous lesions
- Patient global assessment and inflammatory markers in patients with idiopathic inflammatory myopathies: a longitudinal study
- Patients with anti-small ubiquitin-like modifier activating enzyme-positive dermatomyositis resembling antisynthetase syndrome with poor prognosis: a bicentric international retrospective study and literature review
- Beyond medicine: Physical exercise should be always considered in patients with systemic autoimmune myopathies
- Effect of atorvastatin on muscle tissues of dermatomyositis and antisynthetase syndrome patients with dyslipidemia
- Transcriptional response to GAA deficiency (Pompe disease) in infantile-onset patients
- Mutation screening of acid alpha-1,4-glucosidase gene in 64 patients from latin american
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
